In 2017, the National Committee established a new Track II dialogue between the United States and China to discuss issues surrounding healthcare faced by both nations, in partnership with the National School of Development (NSD) at Peking University. Under the theme, “Providing Effective Healthcare,” this new ongoing dialogue examines the effectiveness of the healthcare systems in China and the United States and recommends ways to better measure and manage the delivery and efficiency of healthcare in the two countries. In addressing the topic, participants consider the current plans of and challenges facing both nations, including, in the case of China, the proposals for “Healthy China” set out in the 13th Five-Year Plan, and, in the case of the United States, ongoing changes to the healthcare system.

The dialogue participants are evenly divided between the United States and China, and are experts in the field, along with corporate representatives from different industrial sectors. The United States team is led by Dr. Mark McClellan, former commissioner of the FDA and administrator of the Centers for Medicare and Medicaid Services. The leader of the Chinese delegation is Dr. Liu Qian, former vice minister of the Ministry of Health. Heading the NSD’s efforts is Dr. Gordon Liu, a leading expert on health and development economics who sits on the China State Council Health Reform Advisory Commission.

2018 U.S.-China Track II Dialogue on Healthcare (United States)

November 5, 2018 to November 7, 2018

The third healthcare dialogue was held at Airlie, a conference center in Warrenton, Virginia, outside Washington, D.C. The dialogue brought together eight American participants and eight Chinese participants, consisting of experts in the field and representatives of major healthcare companies, as well as three observers from both countries. Past dialogues have developed a common understanding and foundation for addressing key shared challenges between both countries. The third dialogue built on these themes, recognizing that achieving progress will require more ongoing collaboration between the United States and China, and that such healthcare collaborations can help address the growing tensions related to trade between the two nations. The two sides discussed a wide range of topics, including medical technology development; health insurance reform and the role of the private sector; advancing value-based care models; public health; and areas of possible cooperation in healthcare between the United States and China. On the third day, Chinese participants attended the Chinese Hospital Association’s forum in downtown Washington, D.C., and met with the Kaiser J. Family Foundation. Each dialogue session concludes with a consensus agreement, setting out key points of discussion among the participants, and suggestions for policy changes. This document is circulated to relevant departments in both governments for their consideration.

Connect with Us

Support Us

The National Committee on United States-China Relations, Inc., welcomes financial and in-kind contributions. The Committee is a 501(c)(3) not-for-profit organization and, as such, donations to it are tax-deductible to the extent permitted by law.